The weight-loss pharmaceutical landscape has officially turned into a high-stakes legal battleground. Novo Nordisk, the powerhouse behind the household names Ozempic and Wegovy, recently launched a significant lawsuit against its primary rival, Eli Lilly. At the heart of the dispute is Eli Lilly’s marketing strategy for Zepbound, a competing weight-loss medication. Novo Nordisk contends that these advertisements are not merely aggressive, but fundamentally deceptive, misleading the public by painting an inaccurate picture of how the two drugs compare in efficacy. The core of Novo Nordisk’s grievance lies in how the data was presented. They argue that Eli Lilly’s promotional materials…

In July 2026, a wave of alarm rippled across social media after a Facebook user named Joe Anim posted a startling claim: South Africa’s national broadcaster, SABC, had allegedly reported that Ghana was battling a massive Ebola outbreak, citing over 2,300 cases and nearly 1,000 deaths. Accompanied by screenshots of a news ticker, the post sparked significant concern and confusion among the public. Accusing the broadcaster of not just poor journalism but malicious misinformation, Anim’s post quickly drew hundreds of reactions and shares, igniting a digital firestorm that forced a closer look at the integrity of the information being broadcast…